Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Xylose-binding protein XylFII and sensor histidine kinase LytS complex (XylFII-LytS) is a bacterial signaling assembly that mediates the perception of environmental D-xylose, primarily characterized in Firmicutes such as Clostridium beijerinckii (Li et al., 2017). This complex is part of a three-component system that includes the cytoplasmic response regulator YesN (Gu et al., 2015). In the absence of xylose, XylFII and the N-terminal periplasmic domain of LytS (LytSN) form an inactive heterodimer (Li et al., 2017). Upon binding D-xylose, XylFII undergoes a significant conformational change—closing its binding cleft—which promotes the assembly of an active heterotetramer (PDB: 5XSJ). This structural transition activates the LytS histidine kinase, leading to the phosphorylation of YesN and the subsequent transcriptional activation of the xylFGH operon, which encodes a high-affinity xylose ABC transporter (Li et al., 2017). While not a traditional human therapeutic target, the XylFII-LytS complex is a critical target for metabolic engineering aimed at enhancing the efficiency of xylose fermentation for the production of biofuels and bio-based chemicals (Wang et al., 2019).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Xylose-binding protein XylFII and sensor histidine kinase LytS complex (XylFII-LytS).